Burke A, Borot F, Du X, Churchill M, et al. A novel therapeutic bispecific format based on synthetic orthogonal heterodimers enables T cell activity against Acute myeloid leukemia. Oncogene 2022 Nov 10. pii: 10.1038/s41388-022-02532.
PMID: 36357573